Curr Diabetes Rev 14(3):273279 Mousavi A et al (2025) Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
European Food Safety Authority, 2012
Prospects SAMe, as a universal methyl donor, clearly shows promise in the treatment of neuropsychiatric diseases throughout the human life span
However, chronic early dosing (every 6 days instead of 7) can build up higher-than-intended drug concentrations and increase nausea, vomiting, or gastric upset
Research suggests that chicken protein may naturally support your body's own GLP-1 response, working alongside your medication rather than against it
Regulation of taurine transport in human colon carcinoma cell lines (HT-29 and Caco-2) by protein kinase C